Zantac Patent

New York, NY: (Jan-28-08) Drug developer Cypress Pharmaceutical Inc. had been locked in a patent infringement lawsuit with a unit of British drug maker GlaxoSmithKline PLC related to a generic version of Glaxo's Zantac syrup to treat symptoms of heartburn. Sources close to the case stated that privately held Cypress Pharma said Glaxo agreed not to assert its patent against Cypress' new alcohol-free version of ranitidine oral syrup, also known as Zantac syrup. Cypress officials said that the company expects to launch the product immediately upon receiving approval from the Food and Drug Administration. The settlement resulted in Glaxo's Glaxo Group Ltd. and Cypress filing to dismiss their pending patent litigation in the US District Court for the Southern District of New York. Sources on both sides did not disclose the details of the deal. [CNN NEWS: ZANTAC PATENT]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.

Please click here for a free evaluation of your claim

Published on Jan-28-08